| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |